Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -43.11% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.11% | -- | -- | -- | -- |
| Cost of Revenue | -39.35% | -13.94% | 28.53% | 57.15% | -70.46% |
| Gross Profit | 38.63% | 22.26% | -18.31% | -33.45% | 75.19% |
| SG&A Expenses | -22.97% | -11.18% | 4.69% | -0.31% | -22.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.14% | -12.73% | 18.81% | 28.51% | -5.88% |
| Operating Income | 31.06% | 17.41% | -12.75% | -16.63% | 14.33% |
| Income Before Tax | -134.20% | 14.03% | -18.23% | -19.69% | 17.03% |
| Income Tax Expenses | 517.48% | -- | -96.67% | -- | -- |
| Earnings from Continuing Operations | -136.06% | 13.99% | -18.07% | -19.58% | 16.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -136.06% | 13.99% | -18.07% | -19.58% | 16.62% |
| EBIT | 31.06% | 17.41% | -12.75% | -16.63% | 14.33% |
| EBITDA | 30.08% | 19.48% | -10.99% | -14.80% | 15.91% |
| EPS Basic | -134.84% | 14.80% | -12.99% | -2.20% | 52.96% |
| Normalized Basic EPS | 29.77% | 14.84% | -13.14% | -2.29% | 53.19% |
| EPS Diluted | -134.84% | 14.80% | -12.99% | -2.20% | 52.96% |
| Normalized Diluted EPS | 29.77% | 14.84% | -13.14% | -2.29% | 53.19% |
| Average Basic Shares Outstanding | 0.51% | 0.95% | 4.50% | 17.02% | 77.24% |
| Average Diluted Shares Outstanding | 0.51% | 0.95% | 4.50% | 17.02% | 77.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |